Skip to main content
See every side of every news story
Published • loading... • Updated

Cognito Reports Pivotal Phase 3 Results for Spectris AD, a Non-Invasive, At-Home Approach for Alzheimer's Treatment, Backed by ADDF Investment

In a yearlong trial of more than 670 participants, the Spectris device slowed decline by 56% in mild cases but not in moderate cases.

Summary by Daily Journal
Study misses primary endpoint, but prespecified analysis suggests possible benefit in mild Alzheimer's, pointing to a potential role for devices alongside drugs in future treatment

Bias Distribution

  • 67% of the sources lean Left
67% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

PressNewsAgency broke the news on Monday, November 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal